Live Breaking News & Updates on Scientific Community Engagement

Stay updated with breaking news from Scientific community engagement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Transcripts For CSPAN U.S. House Of Representatives U.S. House Of Representatives 20240713

On their own comprehensive pfas action plan. And we must listen to science rather than regulating new devices and dreams out of existence. Heres the bottom line. We cannot ignore the benefits that some pfas chemicals have given to humankind. I strongly urge the adoption of the balderson amendment and i yield back the balance of my time. The chair the gentleman yields. The gentleman from ohio is ecognized. I thank my friend for his words. Madam chair, i reserve. The chair the gentleman reserves the balance of his time. The gentleman from new york is recognized. Mr. Tonko i yield back. The chair the gentleman yields back the balance of his time. The gentleman from ohio is recognized. Thank you, madam chair. I am prepared to close. The chair the gentleman is recognized to close. Thank you. Madam chair, my closing statement would be the administration has demonstrated that one of its Top Priorities is the research and necessary regula ....

United States , West Bank , Virgin Islands , Nassau County , New York , New Hampshire , Republic Of , Puerto Rico , Sankt Peterburg , North Korea , Michael Fitzpatrick , Peter King , Statement Administration , Top Priorities , Priorities Research , Public Safety , Opportunity Congress , American Public , House Resolution , Energy Commerce , Energy Commerce Committee , Commerce Committee , Home Test , Many Chamber , Industrial Facility , Sewage Treatment ,

Investegate |Hemogenyx Pharma Plc Announcements | Hemogenyx Pharma Plc: Final Results


 
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU AS IT FORMS PART OF LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.
 
 
Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for deadly blood diseases, announces its results for the year ended 31 December 2020.
 
• Demonstrated that HEMO-CAR-T cells are effective against Acute Myloid Leukemia in vitro and in vivo
• Developed a
novel cell-based platform technology, referred to as CBR, for the treatment of emerging viral diseases, including COVID-19, as well as certain types of cancer ....

New York , United States , Cornell University , United Kingdom , City Of , Saar Gill , Alexis Sandler , Lucy Williams , Vladislav Sandler , Eli Lilly , Craig Auringer , Peter Redmond , Marc Feldmann , Samantha Bauer , Charles Goodfellow , Vadim Alexandre , Duncan Vasey , Matthew Johnson , Randall Tlachac , European Patent Office , Company Human Postnatal Hemogenic Endothelial Cells , Catalyst Corporate Consultants Ltd , Janssen Research Development , Orgenesis Inc , Quality Systems , Trademark Office ,